Physicians Protocol Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
GREENSBORO, N.C.--(BUSINESS WIRE)--Apr 4, 2019--Karl Stonecipher, MD at Physicians Protocol, is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.
“Over the course of my career, I have made it my mission to deliver the best outcomes possible for my cataract patients. That it is why it is so exciting for me and the entire Physicians Protocol team to be part of the AcuFocus IC-8 lens clinical study. During the study, we will be exploring whether small aperture technology can be used with a traditional IOL to extend a cataract patient’s range of vision from near to far.”
By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.
Dr. Karl Stonecipher will be one of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.
Physicians Protocol is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:
- At least 22 years of age.
- Have cataracts in both eyes.
- Are available, willing and able to participate in examinations and all follow-up study visits and appointments.
If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Amanda Carls at Physicians Protocol at 815-822-3546 or at email@example.com.
Physicians Protocol, located in Greensboro, North Carolina, has been providing high quality care to patients for over 20 years. Our highly trained physicians are board certified in the medical and surgical treatment of eye diseases. We are a comprehensive ophthalmology practice and specialize in routine eye care as well as complex medical and surgical eye diseases.
1002 N. Church St., Suite 101
Greensboro, NC 27401
ABOUT THE IC-8 IOL
Caution: Investigational Device. Limited by Federal (or United States) law to investigational use. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190404005227/en/
CONTACT: Shelle Murach
Cunningham & Associates
KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA
INDUSTRY KEYWORD: SENIORS WOMEN HEALTH CLINICAL TRIALS OPTICAL OTHER HEALTH CONSUMER GENERAL HEALTH MEN
SOURCE: Physicians Protocol
Copyright Business Wire 2019.
PUB: 04/04/2019 09:05 AM/DISC: 04/04/2019 09:05 AM